Psoriasis involving the hands and feet affects only about 30% of patients with plaque psoriasis, but is a uniquely problematic form of the disease (Fretzin, Crowley, Jones, Young, & Sobell ...

Examples include scalp, hands and feet, and genitals ... a recent study of apremilast in patients with mild/moderate plaque psoriasis that had not responded to one or more topical therapies.

Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

Currently, there is no known cure for psoriasis, although a number ... with chronic moderate-to-severe plaque psoriasis involving the hands and feet. The 12-week study was the first randomized ...